We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

The Elimination Of A Patent Licensing “Safe Haven”

Law360 (April 2, 2007, 12:00 AM EDT) -- In SanDisk, the Federal Circuit applied the Supreme Court’s MedImmune decision (MedImmune Inc. v. Genentech Inc., 127 S. Ct. 764, 166 L. Ed. 2d 604 (2007)) to patent licensing negotiations, and effected “a sweeping change in [Federal Circuit] law regarding declaratory judgment jurisdiction” with potentially “no practical stopping point short of allowing declaratory judgment actions in virtually any case in which the recipient of an invitation to take a patent license elects to dispute the need for a license and then to sue the patentee.” SanDisk...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.